img

Global NGS-based RNA-sequencing Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global NGS-based RNA-sequencing Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Gene expression studies can also involve looking at profiles or patterns of expression of several genes. RNA sequencing (RNA-Seq) leverages the advantages of next-generation sequencing (NGS) to detect and quantify RNA in a biological sample at a given point in time.
NGS-based RNA-sequencing report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global NGS-based RNA-sequencing market is projected to reach US$ 5746.2 million in 2034, increasing from US$ 1832.5 million in 2022, with the CAGR of 17.4% during the period of 2024 to 2034. Demand from Research & Academia and Hospitals & Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for NGS-based RNA-sequencing industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, NGS-based RNA-sequencing key companies include Illumina, Thermo Fischer Scientific, Oxford Nanopore, Agilent Technologies, BGI, PerkinElmer, QIAGEN, Eurofins Scientific and Roche, etc. Illumina, Thermo Fischer Scientific, Oxford Nanopore are top 3 players and held % share in total in 2022.
NGS-based RNA-sequencing can be divided into Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing and Nanopore Sequencing, etc. Sequencing by Synthesis is the mainstream product in the market, accounting for % share globally in 2022.
NGS-based RNA-sequencing is widely used in various fields, such as Research & Academia, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Others, etc. Research & Academia provides greatest supports to the NGS-based RNA-sequencing industry development. In 2022, global % share of NGS-based RNA-sequencing went into Research & Academia filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global NGS-based RNA-sequencing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Illumina
Thermo Fischer Scientific
Oxford Nanopore
Agilent Technologies
BGI
PerkinElmer
QIAGEN
Eurofins Scientific
Roche
Takara Bio
GENEWIZ
Hamilton
Macrogen
Zymo Research
Tecan Genomics
Segment by Type
Sequencing by Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing

Segment by Application


Research & Academia
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the NGS-based RNA-sequencing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, NGS-based RNA-sequencing introduction, etc. NGS-based RNA-sequencing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of NGS-based RNA-sequencing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of NGS-based RNA-sequencing
1.1 NGS-based RNA-sequencing Market Overview
1.1.1 NGS-based RNA-sequencing Product Scope
1.1.2 NGS-based RNA-sequencing Market Status and Outlook
1.2 Global NGS-based RNA-sequencing Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global NGS-based RNA-sequencing Market Size by Region (2024-2034)
1.4 Global NGS-based RNA-sequencing Historic Market Size by Region (2024-2024)
1.5 Global NGS-based RNA-sequencing Market Size Forecast by Region (2024-2034)
1.6 Key Regions, NGS-based RNA-sequencing Market Size (2024-2034)
1.6.1 North America NGS-based RNA-sequencing Market Size (2024-2034)
1.6.2 Europe NGS-based RNA-sequencing Market Size (2024-2034)
1.6.3 Asia-Pacific NGS-based RNA-sequencing Market Size (2024-2034)
1.6.4 Latin America NGS-based RNA-sequencing Market Size (2024-2034)
1.6.5 Middle East & Africa NGS-based RNA-sequencing Market Size (2024-2034)
2 NGS-based RNA-sequencing Market by Type
2.1 Introduction
2.1.1 Sequencing by Synthesis
2.1.2 Ion Semiconductor Sequencing
2.1.3 Single-molecule Real-time Sequencing
2.1.4 Nanopore Sequencing
2.2 Global NGS-based RNA-sequencing Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global NGS-based RNA-sequencing Historic Market Size by Type (2024-2024)
2.2.2 Global NGS-based RNA-sequencing Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America NGS-based RNA-sequencing Revenue Breakdown by Type (2024-2034)
2.3.2 Europe NGS-based RNA-sequencing Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific NGS-based RNA-sequencing Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America NGS-based RNA-sequencing Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa NGS-based RNA-sequencing Revenue Breakdown by Type (2024-2034)
3 NGS-based RNA-sequencing Market Overview by Application
3.1 Introduction
3.1.1 Research & Academia
3.1.2 Hospitals & Clinics
3.1.3 Pharmaceutical & Biotechnology Companies
3.1.4 Others
3.2 Global NGS-based RNA-sequencing Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global NGS-based RNA-sequencing Historic Market Size by Application (2024-2024)
3.2.2 Global NGS-based RNA-sequencing Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America NGS-based RNA-sequencing Revenue Breakdown by Application (2024-2034)
3.3.2 Europe NGS-based RNA-sequencing Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific NGS-based RNA-sequencing Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America NGS-based RNA-sequencing Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa NGS-based RNA-sequencing Revenue Breakdown by Application (2024-2034)
4 NGS-based RNA-sequencing Competition Analysis by Players
4.1 Global NGS-based RNA-sequencing Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NGS-based RNA-sequencing as of 2022)
4.3 Date of Key Players Enter into NGS-based RNA-sequencing Market
4.4 Global Top Players NGS-based RNA-sequencing Headquarters and Area Served
4.5 Key Players NGS-based RNA-sequencing Product Solution and Service
4.6 Competitive Status
4.6.1 NGS-based RNA-sequencing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Illumina
5.1.1 Illumina Profile
5.1.2 Illumina Main Business
5.1.3 Illumina NGS-based RNA-sequencing Products, Services and Solutions
5.1.4 Illumina NGS-based RNA-sequencing Revenue (US$ Million) & (2024-2024)
5.1.5 Illumina Recent Developments
5.2 Thermo Fischer Scientific
5.2.1 Thermo Fischer Scientific Profile
5.2.2 Thermo Fischer Scientific Main Business
5.2.3 Thermo Fischer Scientific NGS-based RNA-sequencing Products, Services and Solutions
5.2.4 Thermo Fischer Scientific NGS-based RNA-sequencing Revenue (US$ Million) & (2024-2024)
5.2.5 Thermo Fischer Scientific Recent Developments
5.3 Oxford Nanopore
5.3.1 Oxford Nanopore Profile
5.3.2 Oxford Nanopore Main Business
5.3.3 Oxford Nanopore NGS-based RNA-sequencing Products, Services and Solutions
5.3.4 Oxford Nanopore NGS-based RNA-sequencing Revenue (US$ Million) & (2024-2024)
5.3.5 Agilent Technologies Recent Developments
5.4 Agilent Technologies
5.4.1 Agilent Technologies Profile
5.4.2 Agilent Technologies Main Business
5.4.3 Agilent Technologies NGS-based RNA-sequencing Products, Services and Solutions
5.4.4 Agilent Technologies NGS-based RNA-sequencing Revenue (US$ Million) & (2024-2024)
5.4.5 Agilent Technologies Recent Developments
5.5 BGI
5.5.1 BGI Profile
5.5.2 BGI Main Business
5.5.3 BGI NGS-based RNA-sequencing Products, Services and Solutions
5.5.4 BGI NGS-based RNA-sequencing Revenue (US$ Million) & (2024-2024)
5.5.5 BGI Recent Developments
5.6 PerkinElmer
5.6.1 PerkinElmer Profile
5.6.2 PerkinElmer Main Business
5.6.3 PerkinElmer NGS-based RNA-sequencing Products, Services and Solutions
5.6.4 PerkinElmer NGS-based RNA-sequencing Revenue (US$ Million) & (2024-2024)
5.6.5 PerkinElmer Recent Developments
5.7 QIAGEN
5.7.1 QIAGEN Profile
5.7.2 QIAGEN Main Business
5.7.3 QIAGEN NGS-based RNA-sequencing Products, Services and Solutions
5.7.4 QIAGEN NGS-based RNA-sequencing Revenue (US$ Million) & (2024-2024)
5.7.5 QIAGEN Recent Developments
5.8 Eurofins Scientific
5.8.1 Eurofins Scientific Profile
5.8.2 Eurofins Scientific Main Business
5.8.3 Eurofins Scientific NGS-based RNA-sequencing Products, Services and Solutions
5.8.4 Eurofins Scientific NGS-based RNA-sequencing Revenue (US$ Million) & (2024-2024)
5.8.5 Eurofins Scientific Recent Developments
5.9 Roche
5.9.1 Roche Profile
5.9.2 Roche Main Business
5.9.3 Roche NGS-based RNA-sequencing Products, Services and Solutions
5.9.4 Roche NGS-based RNA-sequencing Revenue (US$ Million) & (2024-2024)
5.9.5 Roche Recent Developments
5.10 Takara Bio
5.10.1 Takara Bio Profile
5.10.2 Takara Bio Main Business
5.10.3 Takara Bio NGS-based RNA-sequencing Products, Services and Solutions
5.10.4 Takara Bio NGS-based RNA-sequencing Revenue (US$ Million) & (2024-2024)
5.10.5 Takara Bio Recent Developments
5.11 GENEWIZ
5.11.1 GENEWIZ Profile
5.11.2 GENEWIZ Main Business
5.11.3 GENEWIZ NGS-based RNA-sequencing Products, Services and Solutions
5.11.4 GENEWIZ NGS-based RNA-sequencing Revenue (US$ Million) & (2024-2024)
5.11.5 GENEWIZ Recent Developments
5.12 Hamilton
5.12.1 Hamilton Profile
5.12.2 Hamilton Main Business
5.12.3 Hamilton NGS-based RNA-sequencing Products, Services and Solutions
5.12.4 Hamilton NGS-based RNA-sequencing Revenue (US$ Million) & (2024-2024)
5.12.5 Hamilton Recent Developments
5.13 Macrogen
5.13.1 Macrogen Profile
5.13.2 Macrogen Main Business
5.13.3 Macrogen NGS-based RNA-sequencing Products, Services and Solutions
5.13.4 Macrogen NGS-based RNA-sequencing Revenue (US$ Million) & (2024-2024)
5.13.5 Macrogen Recent Developments
5.14 Zymo Research
5.14.1 Zymo Research Profile
5.14.2 Zymo Research Main Business
5.14.3 Zymo Research NGS-based RNA-sequencing Products, Services and Solutions
5.14.4 Zymo Research NGS-based RNA-sequencing Revenue (US$ Million) & (2024-2024)
5.14.5 Zymo Research Recent Developments
5.15 Tecan Genomics
5.15.1 Tecan Genomics Profile
5.15.2 Tecan Genomics Main Business
5.15.3 Tecan Genomics NGS-based RNA-sequencing Products, Services and Solutions
5.15.4 Tecan Genomics NGS-based RNA-sequencing Revenue (US$ Million) & (2024-2024)
5.15.5 Tecan Genomics Recent Developments
6 North America
6.1 North America NGS-based RNA-sequencing Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe NGS-based RNA-sequencing Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America NGS-based RNA-sequencing Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 NGS-based RNA-sequencing Market Dynamics
11.1 NGS-based RNA-sequencing Industry Trends
11.2 NGS-based RNA-sequencing Market Drivers
11.3 NGS-based RNA-sequencing Market Challenges
11.4 NGS-based RNA-sequencing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market NGS-based RNA-sequencing Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global NGS-based RNA-sequencing Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global NGS-based RNA-sequencing Market Size Share by Region (2024-2024)
Table 4. Global NGS-based RNA-sequencing Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global NGS-based RNA-sequencing Forecasted Market Size Share by Region (2024-2034)
Table 6. Global NGS-based RNA-sequencing Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global NGS-based RNA-sequencing Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global NGS-based RNA-sequencing Revenue Market Share by Type (2024-2024)
Table 9. Global NGS-based RNA-sequencing Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global NGS-based RNA-sequencing Revenue Market Share by Type (2024-2034)
Table 11. North America NGS-based RNA-sequencing Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America NGS-based RNA-sequencing Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe NGS-based RNA-sequencing Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe NGS-based RNA-sequencing Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific NGS-based RNA-sequencing Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific NGS-based RNA-sequencing Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America NGS-based RNA-sequencing Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America NGS-based RNA-sequencing Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa NGS-based RNA-sequencing Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa NGS-based RNA-sequencing Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global NGS-based RNA-sequencing Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global NGS-based RNA-sequencing Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global NGS-based RNA-sequencing Revenue Market Share by Application (2024-2024)
Table 24. Global NGS-based RNA-sequencing Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global NGS-based RNA-sequencing Revenue Market Share by Application (2024-2034)
Table 26. North America NGS-based RNA-sequencing Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America NGS-based RNA-sequencing Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe NGS-based RNA-sequencing Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe NGS-based RNA-sequencing Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific NGS-based RNA-sequencing Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific NGS-based RNA-sequencing Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America NGS-based RNA-sequencing Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America NGS-based RNA-sequencing Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa NGS-based RNA-sequencing Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa NGS-based RNA-sequencing Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global NGS-based RNA-sequencing Revenue (US$ Million) by Players (2024-2024)
Table 37. Global NGS-based RNA-sequencing Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NGS-based RNA-sequencing as of 2022)
Table 39. Date of Key Players Enter into NGS-based RNA-sequencing Market
Table 40. Global NGS-based RNA-sequencing Key Players Headquarters and Area Served
Table 41. NGS-based RNA-sequencing Product Solution and Service
Table 42. Global NGS-based RNA-sequencing Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Illumina Basic Information List
Table 45. Illumina Description and Business Overview
Table 46. Illumina NGS-based RNA-sequencing Products, Services and Solutions
Table 47. Revenue (US$ Million) in NGS-based RNA-sequencing Business of Illumina (2024-2024)
Table 48. Illumina Recent Developments
Table 49. Thermo Fischer Scientific Basic Information List
Table 50. Thermo Fischer Scientific Description and Business Overview
Table 51. Thermo Fischer Scientific NGS-based RNA-sequencing Products, Services and Solutions
Table 52. Revenue (US$ Million) in NGS-based RNA-sequencing Business of Thermo Fischer Scientific (2024-2024)
Table 53. Thermo Fischer Scientific Recent Developments
Table 54. Oxford Nanopore Basic Information List
Table 55. Oxford Nanopore Description and Business Overview
Table 56. Oxford Nanopore NGS-based RNA-sequencing Products, Services and Solutions
Table 57. Revenue (US$ Million) in NGS-based RNA-sequencing Business of Oxford Nanopore (2024-2024)
Table 58. Oxford Nanopore Recent Developments
Table 59. Agilent Technologies Basic Information List
Table 60. Agilent Technologies Description and Business Overview
Table 61. Agilent Technologies NGS-based RNA-sequencing Products, Services and Solutions
Table 62. Revenue (US$ Million) in NGS-based RNA-sequencing Business of Agilent Technologies (2024-2024)
Table 63. Agilent Technologies Recent Developments
Table 64. BGI Basic Information List
Table 65. BGI Description and Business Overview
Table 66. BGI NGS-based RNA-sequencing Products, Services and Solutions
Table 67. Revenue (US$ Million) in NGS-based RNA-sequencing Business of BGI (2024-2024)
Table 68. BGI Recent Developments
Table 69. PerkinElmer Basic Information List
Table 70. PerkinElmer Description and Business Overview
Table 71. PerkinElmer NGS-based RNA-sequencing Products, Services and Solutions
Table 72. Revenue (US$ Million) in NGS-based RNA-sequencing Business of PerkinElmer (2024-2024)
Table 73. PerkinElmer Recent Developments
Table 74. QIAGEN Basic Information List
Table 75. QIAGEN Description and Business Overview
Table 76. QIAGEN NGS-based RNA-sequencing Products, Services and Solutions
Table 77. Revenue (US$ Million) in NGS-based RNA-sequencing Business of QIAGEN (2024-2024)
Table 78. QIAGEN Recent Developments
Table 79. Eurofins Scientific Basic Information List
Table 80. Eurofins Scientific Description and Business Overview
Table 81. Eurofins Scientific NGS-based RNA-sequencing Products, Services and Solutions
Table 82. Revenue (US$ Million) in NGS-based RNA-sequencing Business of Eurofins Scientific (2024-2024)
Table 83. Eurofins Scientific Recent Developments
Table 84. Roche Basic Information List
Table 85. Roche Description and Business Overview
Table 86. Roche NGS-based RNA-sequencing Products, Services and Solutions
Table 87. Revenue (US$ Million) in NGS-based RNA-sequencing Business of Roche (2024-2024)
Table 88. Roche Recent Developments
Table 89. Takara Bio Basic Information List
Table 90. Takara Bio Description and Business Overview
Table 91. Takara Bio NGS-based RNA-sequencing Products, Services and Solutions
Table 92. Revenue (US$ Million) in NGS-based RNA-sequencing Business of Takara Bio (2024-2024)
Table 93. Takara Bio Recent Developments
Table 94. GENEWIZ Basic Information List
Table 95. GENEWIZ Description and Business Overview
Table 96. GENEWIZ NGS-based RNA-sequencing Products, Services and Solutions
Table 97. Revenue (US$ Million) in NGS-based RNA-sequencing Business of GENEWIZ (2024-2024)
Table 98. GENEWIZ Recent Developments
Table 99. Hamilton Basic Information List
Table 100. Hamilton Description and Business Overview
Table 101. Hamilton NGS-based RNA-sequencing Products, Services and Solutions
Table 102. Revenue (US$ Million) in NGS-based RNA-sequencing Business of Hamilton (2024-2024)
Table 103. Hamilton Recent Developments
Table 104. Macrogen Basic Information List
Table 105. Macrogen Description and Business Overview
Table 106. Macrogen NGS-based RNA-sequencing Products, Services and Solutions
Table 107. Revenue (US$ Million) in NGS-based RNA-sequencing Business of Macrogen (2024-2024)
Table 108. Macrogen Recent Developments
Table 109. Zymo Research Basic Information List
Table 110. Zymo Research Description and Business Overview
Table 111. Zymo Research NGS-based RNA-sequencing Products, Services and Solutions
Table 112. Revenue (US$ Million) in NGS-based RNA-sequencing Business of Zymo Research (2024-2024)
Table 113. Zymo Research Recent Developments
Table 114. Tecan Genomics Basic Information List
Table 115. Tecan Genomics Description and Business Overview
Table 116. Tecan Genomics NGS-based RNA-sequencing Products, Services and Solutions
Table 117. Revenue (US$ Million) in NGS-based RNA-sequencing Business of Tecan Genomics (2024-2024)
Table 118. Tecan Genomics Recent Developments
Table 119. North America NGS-based RNA-sequencing Market Size by Country (2024-2024) & (US$ Million)
Table 120. North America NGS-based RNA-sequencing Market Size by Country (2024-2034) & (US$ Million)
Table 121. Europe NGS-based RNA-sequencing Market Size by Country (2024-2024) & (US$ Million)
Table 122. Europe NGS-based RNA-sequencing Market Size by Country (2024-2034) & (US$ Million)
Table 123. Asia-Pacific NGS-based RNA-sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 124. Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2024-2024) & (US$ Million)
Table 125. Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2024-2034) & (US$ Million)
Table 126. Asia-Pacific NGS-based RNA-sequencing Market Share by Region (2024-2024)
Table 127. Asia-Pacific NGS-based RNA-sequencing Market Share by Region (2024-2034)
Table 128. Latin America NGS-based RNA-sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 129. Latin America NGS-based RNA-sequencing Market Size by Country (2024-2024) & (US$ Million)
Table 130. Latin America NGS-based RNA-sequencing Market Size by Country (2024-2034) & (US$ Million)
Table 131. Middle East & Africa NGS-based RNA-sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 132. Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2024-2024) & (US$ Million)
Table 133. Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2024-2034) & (US$ Million)
Table 134. NGS-based RNA-sequencing Market Trends
Table 135. NGS-based RNA-sequencing Market Drivers
Table 136. NGS-based RNA-sequencing Market Challenges
Table 137. NGS-based RNA-sequencing Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NGS-based RNA-sequencing Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global NGS-based RNA-sequencing Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global NGS-based RNA-sequencing Market Share by Regions: 2022 VS 2034
Figure 4. Global NGS-based RNA-sequencing Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America NGS-based RNA-sequencing Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe NGS-based RNA-sequencing Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific NGS-based RNA-sequencing Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America NGS-based RNA-sequencing Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa NGS-based RNA-sequencing Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Sequencing by Synthesis
Figure 11. Global Sequencing by Synthesis Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Ion Semiconductor Sequencing
Figure 13. Global Ion Semiconductor Sequencing Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Single-molecule Real-time Sequencing
Figure 15. Global Single-molecule Real-time Sequencing Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Product Picture of Nanopore Sequencing
Figure 17. Global Nanopore Sequencing Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 18. Global NGS-based RNA-sequencing Market Size Share by Type: 2022 & 2034
Figure 19. North America NGS-based RNA-sequencing Revenue Market Share by Type (2024-2034)
Figure 20. Europe NGS-based RNA-sequencing Revenue Market Share by Type (2024-2034)
Figure 21. Asia-Pacific NGS-based RNA-sequencing Revenue Market Share by Type (2024-2034)
Figure 22. Latin America NGS-based RNA-sequencing Revenue Market Share by Type (2024-2034)
Figure 23. Middle East and Africa NGS-based RNA-sequencing Revenue Market Share by Type (2024-2034)
Figure 24. Research & Academia Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Hospitals & Clinics Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 26. Pharmaceutical & Biotechnology Companies Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 27. Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 28. Global NGS-based RNA-sequencing Market Size Share by Application: 2022 & 2034
Figure 29. North America NGS-based RNA-sequencing Revenue Market Share by Application (2024-2034)
Figure 30. Europe NGS-based RNA-sequencing Revenue Market Share by Application (2024-2034)
Figure 31. Asia-Pacific NGS-based RNA-sequencing Revenue Market Share by Application (2024-2034)
Figure 32. Latin America NGS-based RNA-sequencing Revenue Market Share by Application (2024-2034)
Figure 33. Middle East and Africa NGS-based RNA-sequencing Revenue Market Share by Application (2024-2034)
Figure 34. NGS-based RNA-sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 35. Global Top 5 and Top 10 Players NGS-based RNA-sequencing Market Share in 2022
Figure 36. North America NGS-based RNA-sequencing Market Share by Country (2024-2034)
Figure 37. U.S. NGS-based RNA-sequencing Market Size (2024-2034) & (US$ Million)
Figure 38. Canada NGS-based RNA-sequencing Market Size (2024-2034) & (US$ Million)
Figure 39. Germany NGS-based RNA-sequencing Market Size (2024-2034) & (US$ Million)
Figure 40. France NGS-based RNA-sequencing Market Size (2024-2034) & (US$ Million)
Figure 41. U.K. NGS-based RNA-sequencing Market Size (2024-2034) & (US$ Million)
Figure 42. Italy NGS-based RNA-sequencing Market Size (2024-2034) & (US$ Million)
Figure 43. Russia NGS-based RNA-sequencing Market Size (2024-2034) & (US$ Million)
Figure 44. Nordic Countries NGS-based RNA-sequencing Market Size (2024-2034) & (US$ Million)
Figure 45. Asia-Pacific NGS-based RNA-sequencing Market Share by Region (2024-2034)
Figure 46. China NGS-based RNA-sequencing Market Size (2024-2034) & (US$ Million)
Figure 47. Japan NGS-based RNA-sequencing Market Size (2024-2034) & (US$ Million)
Figure 48. South Korea NGS-based RNA-sequencing Market Size (2024-2034) & (US$ Million)
Figure 49. Southeast Asia NGS-based RNA-sequencing Market Size (2024-2034) & (US$ Million)
Figure 50. India NGS-based RNA-sequencing Market Size (2024-2034) & (US$ Million)
Figure 51. Australia NGS-based RNA-sequencing Market Size (2024-2034) & (US$ Million)
Figure 52. Latin America NGS-based RNA-sequencing Market Share by Country (2024-2034)
Figure 53. Mexico NGS-based RNA-sequencing Market Size (2024-2034) & (US$ Million)
Figure 54. Brazil NGS-based RNA-sequencing Market Size (2024-2034) & (US$ Million)
Figure 55. Middle East & Africa NGS-based RNA-sequencing Market Share by Country (2024-2034)
Figure 56. Turkey NGS-based RNA-sequencing Market Size (2024-2034) & (US$ Million)
Figure 57. Saudi Arabia NGS-based RNA-sequencing Market Size (2024-2034) & (US$ Million)
Figure 58. UAE NGS-based RNA-sequencing Market Size (2024-2034) & (US$ Million)
Figure 59. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries